These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 25210194)

  • 1. The HERV-K human endogenous retrovirus envelope protein antagonizes Tetherin antiviral activity.
    Lemaître C; Harper F; Pierron G; Heidmann T; Dewannieux M
    J Virol; 2014 Dec; 88(23):13626-37. PubMed ID: 25210194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectious Entry Pathway Mediated by the Human Endogenous Retrovirus K Envelope Protein.
    Robinson LR; Whelan SP
    J Virol; 2016 Jan; 90(7):3640-9. PubMed ID: 26792739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged activity of HERV-K(HML2) in Old World Monkeys accounts for recent integrations and novel recombinant variants.
    Chabukswar S; Grandi N; Tramontano E
    Front Microbiol; 2022; 13():1040792. PubMed ID: 36532485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Infection of Primary CD4
    Young GR; Terry SN; Manganaro L; Cuesta-Dominguez A; Deikus G; Bernal-Rubio D; Campisi L; Fernandez-Sesma A; Sebra R; Simon V; Mulder LCF
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A human endogenous retrovirus-derived gene that can contribute to oncogenesis by activating the ERK pathway and inducing migration and invasion.
    Lemaître C; Tsang J; Bireau C; Heidmann T; Dewannieux M
    PLoS Pathog; 2017 Jun; 13(6):e1006451. PubMed ID: 28651004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of HERV Transcriptome in HIV+ Cells: Absence of HML2 Activation and General Downregulation of Individual HERV Loci.
    Grandi N; Pisano MP; Scognamiglio S; Pessiu E; Tramontano E
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32340287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 interacts with human endogenous retrovirus K (HML-2) envelopes derived from human primary lymphocytes.
    Brinzevich D; Young GR; Sebra R; Ayllon J; Maio SM; Deikus G; Chen BK; Fernandez-Sesma A; Simon V; Mulder LC
    J Virol; 2014 Jun; 88(11):6213-23. PubMed ID: 24648457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation.
    Morrison JH; Guevara RB; Marcano AC; Saenz DT; Fadel HJ; Rogstad DK; Poeschla EM
    J Virol; 2014 Mar; 88(6):3255-72. PubMed ID: 24390322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic flexibility of human endogenous retrovirus type K.
    Dube D; Contreras-Galindo R; He S; King SR; Gonzalez-Hernandez MJ; Gitlin SD; Kaplan MH; Markovitz DM
    J Virol; 2014 Sep; 88(17):9673-82. PubMed ID: 24920813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K(HML2): implications for present-day activity.
    Belshaw R; Dawson AL; Woolven-Allen J; Redding J; Burt A; Tristem M
    J Virol; 2005 Oct; 79(19):12507-14. PubMed ID: 16160178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a functional envelope protein from the HERV-K family of human endogenous retroviruses.
    Dewannieux M; Blaise S; Heidmann T
    J Virol; 2005 Dec; 79(24):15573-7. PubMed ID: 16306628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human endogenous retrovirus K(HML-2) has a broad envelope-mediated cellular tropism and is prone to inhibition at a post-entry, pre-integration step.
    Kramer P; Lausch V; Volkwein A; Hanke K; Hohn O; Bannert N
    Virology; 2016 Jan; 487():121-8. PubMed ID: 26517399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human endogenous retrovirus-K(II) envelope induction protects neurons during HIV/AIDS.
    Bhat RK; Rudnick W; Antony JM; Maingat F; Ellestad KK; Wheatley BM; Tönjes RR; Power C
    PLoS One; 2014; 9(7):e97984. PubMed ID: 24988390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tetherin activities of HIV-1 Vpu and Ebola virus glycoprotein do not involve removal of tetherin from lipid rafts.
    Lopez LA; Yang SJ; Exline CM; Rengarajan S; Haworth KG; Cannon PM
    J Virol; 2012 May; 86(10):5467-80. PubMed ID: 22398279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment.
    Hauser H; Lopez LA; Yang SJ; Oldenburg JE; Exline CM; Guatelli JC; Cannon PM
    Retrovirology; 2010 Jun; 7():51. PubMed ID: 20529266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal.
    Lopez LA; Yang SJ; Hauser H; Exline CM; Haworth KG; Oldenburg J; Cannon PM
    J Virol; 2010 Jul; 84(14):7243-55. PubMed ID: 20444895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human endogenous retrovirus W family envelope gene activates the small conductance Ca2+-activated K+ channel in human neuroblastoma cells through CREB.
    Li S; Liu ZC; Yin SJ; Chen YT; Yu HL; Zeng J; Zhang Q; Zhu F
    Neuroscience; 2013 Sep; 247():164-74. PubMed ID: 23727510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Endogenous Retroviruses Are Ancient Acquired Elements Still Shaping Innate Immune Responses.
    Grandi N; Tramontano E
    Front Immunol; 2018; 9():2039. PubMed ID: 30250470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/cell surface receptors.
    Lavillette D; Marin M; Ruggieri A; Mallet F; Cosset FL; Kabat D
    J Virol; 2002 Jul; 76(13):6442-52. PubMed ID: 12050356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The envelope glycoprotein of human endogenous retrovirus HERV-W induces cellular resistance to spleen necrosis virus.
    Ponferrada VG; Mauck BS; Wooley DP
    Arch Virol; 2003 Apr; 148(4):659-75. PubMed ID: 12664292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.